Multi-electrode assembly for an implantable medical device

Information

  • Patent Grant
  • 8483846
  • Patent Number
    8,483,846
  • Date Filed
    Thursday, April 8, 2010
    14 years ago
  • Date Issued
    Tuesday, July 9, 2013
    11 years ago
Abstract
A method, system, and apparatus are provided for an electrode assembly comprising a plurality of electrodes for use with an implantable medical device for conducting an electrical signal between the implantable medical device and a target tissue. The electrode assembly includes a helical member and first and second electrodes formed upon the helical member. The first and second electrodes are adapted to deliver the electrical signal. The electrode assembly also includes a first conductive element formed upon the helical member and operatively coupled to the first electrode. The electrode assembly also includes a second conductive element formed upon the helical member and operatively coupled to the second electrode.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


This invention relates generally to implantable electrode assemblies, and more particularly to an electrode assembly comprising a plurality of electrodes organized into a helical structure. The electrodes may be operatively coupled to an implantable medical device (IMD).


2. Description of the Related Art


As used herein, “stimulation” or “stimulation signal” refers to the application of an electrical, mechanical, magnetic, electro-magnetic, photonic, audio and/or chemical signal to a neural structure in the patient's body. The signal is an exogenous signal that is distinct from the endogenous electrical, mechanical, and chemical activity (e.g., afferent and/or efferent electrical action potentials) generated by the patient's body and environment. In other words, the stimulation signal (whether electrical, mechanical, magnetic, electro-magnetic, photonic, audio or chemical in nature) applied to the nerve in the present invention is a signal applied from an artificial source, e.g., a neurostimulator.


A “therapeutic signal” refers to a stimulation signal delivered to a patient's body with the intent of treating a disorder by providing a modulating effect to neural tissue. The effect of a stimulation signal on neuronal activity is termed “modulation”; however, for simplicity, the terms “stimulating” and “modulating”, and variants thereof, are sometimes used interchangeably herein. In general, however, the delivery of an exogenous signal itself refers to “stimulation” of the neural structure, while the effects of that signal, if any, on the electrical activity of the neural structure are properly referred to as “modulation.” The effect of delivery of the stimulation signal to the neural tissue may be excitatory or inhibitory and may potentiate acute and/or long-term changes in neuronal activity. For example, the “modulating” effect of the stimulation signal to the neural tissue may comprise one or more of the following effects: (a) changes in neural tissue to initiate an action potential (afferent and/or efferent action potentials); (b) inhibition of conduction of action potentials (whether endogenous or exogenously induced) or blocking the conduction of action potentials (hyperpolarizing or collision blocking), (c) affecting changes in neurotransmitter/neuromodulator release or uptake, and (d) changes in neuro-plasticity or neurogenesis of brain tissue.


Thus, electrical neurostimulation or modulation of a neural structure refers to the application of an exogenous electrical signal (as opposed to mechanical, chemical, photonic, or another mode of signal delivery) to the neural structure. Electrical neurostimulation may be provided by implanting an electrical device underneath the skin of a patient and delivering an electrical signal to a nerve such as a cranial nerve. In one embodiment, the electrical neurostimulation involves sensing or detecting a body parameter, with the electrical signal being delivered in response to the sensed body parameter. This type of stimulation is generally referred to as “active,” “feedback,” or “triggered” stimulation. In another embodiment, the system may operate without sensing or detecting a body parameter once the patient has been diagnosed with a medical condition that may be treated by neurostimulation. In this case, the system may periodically apply a series of electrical pulses to the nerve (e.g., a cranial nerve such as a vagus nerve) intermittently throughout the day, or over another predetermined time interval. This type of stimulation is generally referred to as “passive,” “non-feedback,” or “prophylactic,” stimulation. The stimulation may be applied by an implantable medical device that is implanted within the patient's body. In another alternative embodiment, the signal may be generated by an external pulse generator outside the patient's body, coupled by an RF or wireless link to an implanted electrode.


Generally, neurostimulation signals that perform neuromodulation are delivered by the implantable device via one or more leads. The leads are generally coupled at a distal end to electrodes, which are coupled to a tissue in the patient's body. Multiple leads/electrodes may be attached to various points of a nerve or other tissue inside a human body for delivery of neurostimulation. Generally, each lead is associated with a separate electrode, particularly when each of the electrodes is intended to perform a different function (e.g., deliver a first electrical signal, deliver a second electrical signal, sense a body parameter, etc.).


Generally, a single electrode is associated with each lead originating from the IMD. The number of leads that originate from the IMD is limited due to the size constraints of the IMD and of the patient's body. Therefore, a limited number of electrodes using state-of-the-art technology can be used to deliver electrical stimulation from an IMD.


Further, state-of-the-art medical systems call for performing a stimulation during a time period that is separate from a time period of performing a sensing function for sensing the patient's biological signals. Further, a first lead associated with a first electrode may deliver a therapeutic electrical signal, while a second lead associated with a second electrode may perform data acquisition for sensing of various biometric parameters in the patient's body. This process may be inefficient since the state-of-the-art generally lacks a system for simultaneously delivering an electrical signal to a neural structure and sensing electrical activity, particularly where associated with the neural structure to which the signal is applied. Further, problems with the state-of-the-art also include a limitation on the number of electrodes that may be employed by an IMD to deliver various stages of therapy and/or sensing functions.


SUMMARY OF THE INVENTION

In one aspect, the present invention provides an electrode assembly comprising a plurality of electrodes for use with an implantable medical device for conducting an electrical signal between the implantable medical device and a target tissue. The electrode assembly includes a helical member having a first and a second electrode formed upon the helical member. The first and second electrodes are adapted to deliver the electrical signal. The electrode assembly also includes a first conductive element formed upon the helical member and operatively coupled to the first electrode. The first conductive element is adapted to carry the electrical signal to the first electrode. The electrode assembly also includes a second conductive element formed upon the helical member and operatively coupled to the second electrode.


In yet another aspect, the present invention includes a method for forming a helical electrode assembly for carrying an electrical signal associated with an implantable medical device. A first layer is formed on a generally flat substrate. In one embodiment, the substrate is generally planar. A first conducting structure is formed upon the first layer. The first conducting structure includes a first electrode and a first lead operatively coupled to the first electrode. A second, non-conductive layer is formed above the first layer. A second conducting structure is formed upon the second, non-conductive layer. The second conducting structure includes a second electrode and a second lead operatively coupled to the second electrode. The method further includes the step of forming the generally flat substrate into a helical structure.


In another aspect, the present invention includes another method for forming a helical electrode assembly for carrying a signal associated with an implantable medical device. A first layer is formed on a generally flat substrate. A first conducting structure and a second conducting structure are formed upon the first layer. The first conducting structure includes a first electrode and a first lead operatively coupled to the first electrode. The second conducting structure includes a second electrode and a second lead operatively coupled to the second electrode. A second, non-conductive layer is formed such that the first and second leads are substantially covered by the second layer and the first and second electrodes remain exposed. The method also comprises the step of forming the generally flat substrate and first and second layers into a helical structure.


In yet another aspect, the present invention provides an implantable medical system for providing a therapeutic electrical signal to a target tissue using a helical electrode assembly. The system of the present invention includes an implantable medical device for generating a therapeutic electrical signal. The system also includes a lead assembly operatively coupled to the implantable medical device and adapted to carry the therapeutic electrical signal. The lead assembly comprises first and second lead elements. The system also includes an electrode assembly operatively coupled to the lead assembly. The electrode assembly includes a helical member having first and second electrodes formed thereon. The electrode assembly also includes a first conductive element formed upon the helical member and operatively coupled to the first electrode and to the first lead element. The electrode assembly also includes a second conductive element formed upon the helical member and operatively coupled to the second electrode and to the second lead element. The first and second electrodes are adapted to deliver the electrical signal to tissue of a patient when coupled thereto.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be understood by reference to the following description taken in conjunction with the accompanying drawings, in which like reference numerals identify like elements, and in which:



FIG. 1 is a stylized diagram of an implantable medical device implanted into a patient's body for providing stimulation to a portion of the patient's body, in accordance with one illustrative embodiment of the present invention;



FIG. 2 illustrates a stylized isometric illustration of an electrode assembly in accordance with one embodiment of the present invention;



FIG. 3 illustrates another isometric depiction of the electrode assembly and an electrode in accordance with one illustrative embodiment of the present invention;



FIG. 4 illustrates a stylized depiction of the electrode assembly of FIGS. 2 and 3 during fabrication, in accordance with the illustrated embodiment of the present invention;



FIG. 5 illustrates a flowchart associated with a method for providing the electrode assembly of FIGS. 2-4, in accordance with an illustrative embodiment of the present invention, is provided;



FIG. 6 illustrates a stylized depiction of the electrode assembly of the present invention in a staggered multi-layered configuration, in accordance with an illustrative embodiment of the present invention;



FIG. 7 illustrates a stylized side view of a flexible material upon which a first through third layers and corresponding conductive structures are formed, in accordance with an illustrative embodiment of the present invention; and



FIG. 8 illustrates an alternative stylized depiction of the electrode assembly of the present invention in a multi-layered configuration, in accordance with an illustrative embodiment of the present invention.





While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and are herein described in detail. It should be understood, however, that the description herein of specific embodiments is not intended to limit the invention to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION OF SPECIFIC EMBODIMENTS

Illustrative embodiments of the invention are described herein. In the interest of clarity, not all features of an actual implementation are described in this specification. In the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the design-specific goals, which will vary from one implementation to another. It will be appreciated that such a development effort, while possibly complex and time-consuming, would nevertheless be a routine undertaking for persons of ordinary skill in the art having the benefit of this disclosure.


Certain terms are used throughout the following description and claims to refer to particular system components. This document does not intend to distinguish between components that differ in name but not function. In the following discussion and in the claims, the terms “including” and “includes” are used in an open-ended fashion, and thus should be interpreted to mean “including, but not limited to.” Also, the term “couple” or “couples” is intended to mean either a direct or an indirect electrical connection. “Direct contact,” “direct attachment,” or providing a “direct coupling” indicates that a surface of a first element contacts the surface of a second element with no substantial attenuating medium therebetween. The presence of substances, such as bodily fluids, that do not substantially attenuate electrical connections does not vitiate direct contact. The word “or” is used in the inclusive sense (i.e., “and/or”) unless a specific use to the contrary is explicitly stated.


As used herein, “stimulation” or “stimulation signal” refers to the application of an electrical, mechanical, and/or chemical signal to a neural structure in the patient's body. In one embodiment, the stimulation comprises an electrical signal. The stimulation signal may induce afferent and/or efferent action potentials on the nerve, may block native afferent and/or efferent action potentials, or may be applied at a sub-threshold level that neither generates action potentials nor blocks native action potentials.


The stimulation signal applied to the neural structure in embodiments of the present invention refers to an exogenous signal that is distinct from the endogenous electrical, mechanical, and chemical activity (e.g., afferent and/or efferent electrical action potentials) generated by the patient's body and environment. In other words, the stimulation signal (whether electrical, mechanical or chemical in nature) applied to the nerve in the present invention is from an artificial source, e.g., a neurostimulator.


The term “electrode” or “electrodes” described herein may refer to one or more stimulation electrodes, one or more sensing electrodes, and/or to one or more electrodes that are capable of delivering a stimulation signal as well as performing a sensing function. Stimulation electrodes may refer to an electrode that is capable of delivering a stimulation signal to a tissue of a patient's body. A sensing electrode may refer to an electrode that is capable of sensing a physiological indication of a patient's body. “Electrode” and/or “electrodes” may also refer to one or more electrodes capable of delivering a stimulation signal as well as sensing a physiological indication.


The terms “stimulating” and “stimulator” may generally refer to delivery of a stimulation signal to a neural structure. The effect of such stimulation on neuronal activity is termed “modulation”; however, for simplicity, the terms “stimulating” and “modulating”, and variants thereof, are sometimes used interchangeably herein. In general, however, the delivery of an exogenous signal refers to “stimulation” of the neural structure, while the effects of that signal, if any, on the electrical activity of the neural structure are properly referred to as “modulation.” In one embodiment of the present invention, methods, apparatus, and systems are provided involving a helical electrode to stimulate an autonomic nerve, such as a cranial nerve, e.g., a vagus nerve, using an electrical signal to treat a medical condition such as epilepsy and other movement disorders, mood and other neuropsychiatric disorders, dementia, coma, migraine headache, obesity, eating disorders, sleep disorders, cardiac disorders (such as congestive heart failure and atrial fibrillation), hypertension, endocrine disorders (such as diabetes and hypoglycemia), and pain, among others. A generally suitable form of neurostimulator for use in the method and apparatus of the present invention is disclosed, for example, in U.S. Pat. No. 5,154,172, assigned to the same assignee as the present application. The neurostimulator may be referred to a NeuroCybernetic Prosthesis (NCP®, Cyberonics, Inc., Houston, Tex., the assignee of the present application). Certain parameters of the electrical stimulus generated by the neurostimulator are programmable, such as by means of an external programmer in a manner conventional for implantable electrical medical devices.


Embodiments of the present invention provide for an electrode assembly comprising a plurality of individual electrodes or an array of electrodes. The electrode assembly may be formed as a helical structure, wherein the electrode assembly may comprise a plurality of electrodes and associated conductive elements for delivering various electrical stimulation signals. One or more of the plurality of electrodes associated with the electrode assembly may also provide for the capacity to perform sensing. Therefore, substantially simultaneous delivery of stimulation and the acquisition of sensing signals may be performed utilizing the electrode array of the electrode assembly of the present invention. The term “electrode array” may refer to two or more electrodes residing on a single electrode assembly.


Embodiments of the present invention provide a flexible “ribbon-type” material upon which various electrodes may be provided in a variety of configurations to provide efficient delivery of therapy and/or sensing functions. For example, electrodes may be positioned on a helical member such that successive electrodes are generally linear along an axis of a nerve, such as the vagus nerve. Alternatively, various electrodes on the electrode assembly of the present invention may be positioned in a staggered fashion to deliver a signal in a particular geometry or configuration to target portions of a nerve. An electrode assembly may be employed using a state-of-the-art IMD such that a number of electrodes may be substantially simultaneously activated, or alternatively, activated in a staggered or sequential fashion.


Embodiments of the present invention also provide for a method for manufacturing an electrode assembly that comprises a plurality of electrodes. A non-conductive material may be coated with various layers of conductive and non-conductive films or layers to create various conductive structures, such as electrodes, strips of conductive materials that provide electrical signals to the electrodes, and interfaces that provide connection between the various electrodes on the electrode assembly and lead(s) that are in operative communication with the IMD. For example, photolithography processes may be used on a plurality of layers formed on a substrate to provide various electrodes that are situated at desirable or strategic locations on a single electrode assembly, which may be formed into a helical configuration. This helical configuration may be used to wrap the electrode assembly around various portions of a patient's body, such as a nerve, such that the multiple electrodes may come into contact at desired locations of a particular nerve in a desired geometry or configuration. One or more of the multiple electrodes may be energized in a strategically timed fashion to provide desired stimulation to a portion of a patient's body. This may provide the ability to direct or steer current flow to a pre-determined position and direction, through a portion of a patient's body, such as a nerve. Utilizing embodiments of the present invention more efficient and effective delivery of stimulation may be realized.


Although not so limited, a system capable of implementing embodiments of the present invention is described below. FIG. 1 depicts a stylized implantable medical system 100 for implementing one or more embodiments of the present invention. FIG. 1 illustrates an electrical signal generator 110 having main body comprising a case or shell 112 with a header 116 for connecting to leads 122. The generator 110 is implanted in the patient's chest in a pocket or cavity formed by the implanting surgeon just below the skin, similar to the implantation procedure for a pacemaker pulse generator.


A nerve electrode assembly 125, preferably comprising a plurality of electrodes, is conductively connected to the distal end of an insulated, electrically conductive lead assembly 122, which preferably comprises a plurality of lead wires (one wire for each electrode). Each electrode in the electrode assembly 125 may operate independently or alternatively, may operate in conjunction with each other to form a cathode and an anode. The electrode assembly 125 illustrated in FIG. 1 may be formed into a helical structure that comprises a plurality of electrodes on an inside surface of the helical structure to deliver electrical signals via the plurality of electrodes in a simultaneous or time-delayed fashion, as well as perform efficient sensing of electrical signals in a patient's body.


Lead assembly 122 is attached at its proximal end to connectors on the header 116 on the case 112. The electrode assembly 125 at the distal end of lead assembly 122 may be surgically coupled to a target tissue such as vagus nerve 137. The electrical signal may also be applied to other cranial nerves. The electrode assembly 125 preferably comprises a bipolar stimulating electrode pair, or may comprise three, four or even more electrodes. The electrode assembly 125 is preferably wrapped around the target tissue, such as a vagus nerve. Prior art electrodes have been provided that wrap around a target tissue, such as the electrode pair described in U.S. Pat. No. 4,573,481. In the prior art structures, however, a separate helical element is provided for each electrode. In contrast, the present invention involves a plurality of electrodes on a single helical element. Varying lengths of the helical element may be provided, depending upon the pitch of the helix and the number of electrodes thereon. Lengths may range from 3 mm to 50 mm, although even smaller or longer helices may be employed in particular applications. Lead assembly 122 may be secured, while retaining the ability to flex with movement of the chest and neck, by a suture connection to nearby tissue.


In one embodiment, the open helical design of the electrode assembly 125 is self-sizing and flexible, minimizes mechanical trauma and allows body fluid interchange with the target tissue. The electrode assembly 125 preferably conforms to the shape of the target tissue, providing a low stimulation threshold by allowing a large stimulation contact area. Structurally, the electrode assembly 125 comprises a plurality of electrode ribbons (not shown), of a conductive material such as precious metals and/or alloys and oxides thereof, including platinum, iridium, platinum-iridium alloys, and/or oxides of the foregoing. The electrode ribbons are individually bonded to an inside surface of an elastomeric body portion, which may comprise a helical assembly. The lead assembly 122 may comprise two distinct lead wires or a multi-wire cable whose conductive elements are respectively coupled to one of the conductive electrode ribbons. The elastomeric body portion is preferably composed of silicone rubber, or another biocompatible, durable polymer such as siloxane polymers, polydimethylsiloxanes, polyurethane, polyether urethane, polyetherurethane urea, polyesterurethane, polyamide, polycarbonate, polyester, polypropylene, polyethylene, polystyrene, polyvinyl chloride, polytetrafluoroethylene, polysulfone, cellulose acetate, polymethylmethacrylate, polyethylene, and polyvinylacetate.


The electrical signal generator 110 may be programmed with an external computer 150 using programming software of the type copyrighted by the assignee of the instant application with the Register of Copyrights, Library of Congress, or other suitable software based on the description herein, and a programming wand 155 to facilitate radio frequency (RF) communication between the computer 150 and the signal generator 110. The wand 155 and software permit non-invasive communication with the generator 110 after the latter is implanted, according to means known in the art.


A variety of stimulation therapies may be provided in implantable medical systems 100 of the present invention. Different types of nerve fibers (e.g., A, B, and C fibers being different fibers targeted for stimulation) have different conduction velocities and stimulation thresholds and, therefore, differ in their responsiveness to stimulation. Certain pulses of an electrical stimulation signal, for example, may be below the stimulation threshold for a particular fiber and, therefore, may generate no action potential in the fiber. Thus, smaller or narrower pulses may be used to avoid stimulation of certain nerve fibers (such as C fibers) and target other nerve fibers (such as A and/or B fibers, which generally have lower stimulation thresholds and higher conduction velocities than C fibers). Additionally, techniques such as pre-polarization may be employed wherein particular nerve regions may be polarized before a more robust stimulation is delivered, which may better accommodate particular electrode materials. Furthermore, opposing polarity phases separated by a zero current phase may be used to excite particular axons or postpone nerve fatigue during long term stimulation.


Turning now to FIG. 2, a stylized isometric illustration of a helical electrode assembly 210 in accordance with one embodiment of the present invention is illustrated. The electrode assembly may be formed into a helical configuration and may be made of a flexible material, such as a silicone polymer substrate with semiconductor layers imprinted thereon using photolithography techniques. The electrode assembly may also comprise an end member 220 that provides an interface to a lead wire in electrical communication with the IMD. The helical structure of FIG. 2 may be wrapped around a portion of the patient's body, such as a nerve, e.g., the vagus nerve, and anchored thereupon.


Turning now to FIG. 3, another isometric depiction of the electrode assembly 210, in accordance with one illustrative embodiment of the present invention, is provided. An electrode 330 may be formed on the surface of the inside portion of the electrode assembly 210. The electrode assembly 210 may be wrapped around a target portion of the patient's body, e.g., a nerve, such that the electrode 330 contacts the target portion at a predetermined location. The electrode 330 illustrated in FIG. 3 may comprise a plurality of electrodes formed on the inside surface of various portions of the electrode assembly 210. The electrodes 330 may comprise a conductive material such as platinum, iridium, and/or platinum/iridium alloys and/or oxides. Further details as to the position of the electrodes on the electrode assembly 210 are provided in subsequent drawings and accompanying description below.


Turning now to FIG. 4, a stylized depiction is provided of the electrode assembly 210 during fabrication in accordance with an embodiment of the present invention. The electrode assembly 210 comprises a flexible substrate material 440 on which various electrodes may be formed. Flexible substrate materials 440 upon which a plurality of electrodes may be formed may comprise various materials, such as silicone rubbers, siloxane polymers, and other materials previously noted.


Various conductive structures in a variety of manners may be formed upon the flexible material 440. The conductive structures may include one or more electrodes 410, which are capable of being in contact with a portion of a patient's body, e.g., a nerve, and provide an electrical signal from the signal generator 110 or detect electrical signals in the patient's body. The conductive structures may also include various conductive strips 420 and a plurality of connection pads 430. Each of the electrodes 410 may be respectively coupled electrically to a distal end of one of a plurality of conductive strips 420 that are capable of carrying electrical signals to or from the electrodes 410. Further, each of the conductive strips 420 may be respectively coupled electrically, at a proximal end thereof, to one of the plurality of connection pads 430. The connection pads 430 may then be used as an interface to a wire or a lead structure that may contain several electrical components that may each respectively attach or connect to the set of connection pads 430 illustrated in FIG. 4.


Connection pads 430 may be formed at the edge of the helical structure or on the end portion 220 of FIG. 2. In one embodiment, the end portion 220 may be part of the flexible material 440 (as depicted in FIG. 4), upon which various processes described herein may be used to form the connection pads 430. In an alternative embodiment, the end portion 220 may be a separate structure that is coupled to the helical structure, as indicated in FIGS. 2 and 3. The end portion may house a plurality of connection pads 430. Continuing referring to FIG. 4, in one embodiment, the portion of the flexible material 440 that contains the electrodes 410 may be shaped into a helical form, while the portion of the flexible material 440 that comprises the conductive strips 420 may be shaped into an undulated form, and the portion of the flexible material 440 that comprises the connection pads 430 may be formed in a generally flat configuration. In this manner, a connector (not shown in FIG. 4) may be coupled to the connection pads 430, wherein a lead assembly that comprises a plurality of electrical wires may be operatively coupled to connection pads 430. Therefore, electrical connections between a plurality of electrical wires in a lead assembly may be respectively operatively coupled to a plurality of electrodes 410.


Various methods may be used to form the conductive elements illustrated in FIG. 4 upon the flexible material 440 in a flat or generally planar initial configuration. Semiconductor processing techniques, such as photolithography processes, copper deposition processes, single and/or dual damascene processes, etc., known to those skilled in the art having benefit of the present disclosure, may be employed to form the conductive structures (e.g., 410, 420, 430) upon the flexible material 440. The flexible material 440 may then be formed into a helical structure, wherein the electrodes 410 are located on an inner surface of the helical structure such that the electrodes would be in electrical communication with a patient's body when the electrode assembly 210 is wrapped around a target structure.


In one embodiment, the flexible material 440 is formed into a helical structure after creating conductive structures 410, 420, 430, e.g., on the material 440 while the material 440 is in a flat or generally planar configuration. The flat substrate material 440 is then formed into a helical configuration. In an alternative embodiment, the flexible material 440 is first formed into a helical structure, which is then unfurled into a flat or generally planar configuration. The conductive structures are then created on the unfurled, flat material, and thereafter a restraining force on the unfurled structure is released to allow it to return to a helical configuration. Further, a portion of the flexible material 440 may be shaped in an undulated form. In one embodiment, a portion of the flexible material 440 that comprises conductive structures may be shaped into an undulated form. Known fabrication techniques may be used to form the flexible material into a helical structure and/or into an undulated structure, such as heat treating and/or annealing techniques, and scoring and/or etching portions of the substrate to urge the substrate into a helical configuration.


Turning now to FIG. 5, a flowchart associated with a method for providing the electrode assembly 210 in accordance with an illustrative embodiment of the present invention, is provided. Initially, a substrate is provided comprising a flexible material (block 605). In one embodiment, the substrate is generally flat. In another embodiment, the substrate is generally planar. A base layer or first layer may be formed on the substrate that is part of the flexible material 440 of FIG. 4 (block 610). Numerous types of deposition techniques known to those skilled in the art having benefit of the present disclosure may be used to generate the base layer. Such techniques may include, without limitation, chemical plating, plasma ion deposition, vapor deposition and sputtering. In one embodiment, the base layer is a substantially non-conductive film of material, such as a dielectric material.


A conductive structure may then be formed over the first layer to form a second layer (block 620). The conductive structure may include the electrode 410, the conductive strip 420, the connection pads 430, etc. Various techniques may be used to form the conductive structures on the second layer. The formation of the conductive structure may include various semiconductor processing steps, such as performing a photolithography process (block 622). The photolithography process may use a mask and a light source to provide for deposition of material in a predetermined desired formation to form one or more electrodes 410, conductive strips 420, and/or connection pads 430. An etch process may also be performed on the second layer (block 624). The etch process may be used to etch away excessive deposition material in order to conform the various conductive structures into predetermined shapes and sizes. In one embodiment, an excimer laser may be used to remove excessive deposition material, e.g., removing excessive polymer deposition material to expose a precisely defined surface area for an electrode 410. For example, the dimensions of the electrode may be precisely controlled to provide a width of from about 0.1 mm to about 2.0 mm, with a typical width of about 1.0 mm, and a length of from about 0.1 mm to about 10 mm, typically about 7 mm. The widths of the conductive strips may range from about 20 μm to about 100 μm (0.1 mm), with lengths thereof varying as necessary for a particular application. The connection pads may be provided with dimensions sufficient to allow good electrical connection to a lead wire, which will vary according the application. In one embodiment, the connection pads may be provided with major dimensions ranging from about 20 μm to about 3 mm. Further, a chemical-mechanical polishing (CMP) process may also be performed on the second layer (block 626). Various semiconductor processing techniques may be performed to form the conductive structures over the first layer. Alternatively, a copper deposition process, such as a damascene process or a dual damascene process, may be performed to form the conductive structures of the second layer (block 628).


Upon forming one or more conductive structures over the first layer to form the second layer, a non-conductive layer may then be formed over the second layer, resulting in a third layer (block 630). Another set of conductive structures may then be formed over the third layer to form the fourth layer that contains additional conductive structures (block 640). This set of processes (i.e., forming alternating non-conducting and conducting layers) may then be repeated until a desired number of electrodes, as well as associated conductive strips and connection pads, are formed on the flexible material 440 (block 650). Additionally, upon completion of the formation of the conductive portions on the flexible material, additional coating steps may be performed. The coating steps may include coating the electrode assembly with a non-conductive, flexible coating while masking off the electrodes. Optionally, a lead assembly having a plurality of lead elements may be provided, and the lead elements may be coupled to the electrodes using the connection pads (block 660). In this manner, an electrode assembly 210 with a helical electrode portion comprising a plurality of electrodes, conductive strips, and connection pads is provided. The electrode assembly may be coupled to a lead assembly, which may have an undulated form, using the connection pads. At least a portion of the substrate may be formed into a helical shape (block 670). In one embodiment, the portion of the substrate containing the electrodes may be formed into a helical shape.


Turning now to FIG. 6, a stylized depiction of the electrode assembly of the present invention in a staggered, multi-layered configuration is provided in accordance with an illustrative embodiment of the present invention. The flexible material 440 may comprise a first layer upon which a first electrode 710 and an associated conductive strip 720 are formed into a second layer using the various techniques described above. The conductive strip runs along at least a portion of the length of the flexible material 440 and is illustrated as dotted lines under subsequent layers that are formed on the connector strip (i.e., flexible material) 440, such as a third layer, and a fourth layer.


Upon forming of the first layer and the second layer (which includes the first electrode 710 at a predetermined location, and associated conductive strip 720 that runs along the length of the flexible material 440), a third layer is formed. The third layer is formed at an offset position on the second layer such that the third layer is not formed above the region in which the first electrode 710 resides. Upon the third layer, a fourth layer comprising a second electrode 730 and an associated second conductive strip 740 may be formed. The second conductive strip 740 may run along a portion of the length of the flexible material 440.


Further, offset slightly from the third and fourth layers, a fifth layer may be formed over the fourth layer. The fifth layer is not formed above the portion of the first and second or third and fourth layers upon which the first electrode 710 or the second electrode 730 reside. Upon the fifth layer, a sixth layer comprising a third electrode 750 and an associated third conductive strip 760 are formed. The third conductive strip 760 runs along a portion of the length of the flexible material 440. In this manner, a “stair step” of layers that contain electrodes and conductive strips are generated on a single flexible material 440 until a desired number of electrodes are formed. Further, each layer upon which an electrode is formed may also contain a respective connection pad for coupling the electrode and its associated conductive strip to a lead element. Due to the offsetting of the third and fifth layers, both the conductive strips and the electrodes (in other words, the entire conducting structures) are offset from one another, such that all the electrodes are exposed on the surface of the electrode assembly. In addition, the surface of the electrode assembly is designed so that an electrode is exposed only where it comes into contact with a portion of the patient's body.


Upon forming the flexible material 440 into a helical structure, and subsequently wrapping the helical structure around a portion of the patient's body, such as a nerve, each of the first through third electrodes 710, 730, 750, comes into contact with respective portions of the patient's body without contacting the other electrodes or the conductive strips 720, 740, 760 associated with the other electrodes. That is, each individual electrode is electrically isolated from the other electrodes and from the conductive strips associated with the other electrodes. Thus, different electrical signals can be applied to different regions of the patient's body, independently. Further, the first electrode 710 may deliver a therapeutic stimulation signal, whereas the second electrode 730 may acquire resultant electrical data, e.g., by sensing the activity on the nerve. In this manner, the IMD is capable of independently controlling the electrical activities of each of the electrodes.


Referring simultaneously to FIGS. 7 and 8, a stylized side view of the flexible material 440 upon which the first through sixth layers are formed, is illustrated in FIG. 7. FIG. 8 illustrates the first through seventh layers that are formed above the substrate on the flexible material 440. As depicted in FIG. 7, a first layer is formed above the substrate (substrate not shown in FIG. 7). Above the first layer, the second layer comprising the first electrode 710 and the first conductive strip 720 are formed. Without being formed above the first electrode 710, the third layer is formed, at an offset position on the second layer. The fourth layer, comprising the second electrode 730 and the second conductor strip 740, is formed upon the third layer. The third layer is capable of electrically isolating the conductive structures in the second layer. Similarly, upon forming the conductive structures into a fourth layer above the third layer, the fifth layer is formed at an offset position on the fourth layer, above a portion of the conductive strip portion of the fourth layer and without being formed above the second electrode 730. Upon the fifth layer, a sixth layer comprising the third electrode 750 and the associated third conductive strip 760 are formed. Therefore, the thickness of the overall electrode assembly 210 will depend on the number of electrodes that are formed on the flexible material 440. Due to the offsetting of the third and fifth layers, both the conductive strips and the electrodes (in other words, the entire conducting structures) are offset from one another, such that all the electrodes are exposed on the surface of the electrode assembly. In addition, the surface of the electrode assembly is designed so that an electrode is exposed only where it comes into contact with a portion of the patient's body, such that each individual electrode is electrically isolated from the other electrodes and from the conductive strips associated with the other electrodes. In this manner, each of the first through third electrodes 710, 730, 750, or additional electrodes that may be formed on the flexible material 440, may operate independently. Although only six layers and three electrodes are illustrated for clarity and ease of description, those skilled in the art having benefit of the present invention would readily appreciate that various additional layers may be similarly added and remain within the spirit and scope of the present invention.


Referring to FIG. 8, an alternative embodiment of providing the electrode assembly in accordance with an alternative illustrative embodiment of the present invention, is provided. FIG. 8 illustrates a substrate associated with the flexible material 440. Upon the substrate, a first layer may be formed. Upon the first layer, a second layer comprising a first conductive strip 920 is formed. The second layer is formed at an offset position on the first layer. The first conductive strip 920 may be connected to a corresponding electrode that will be formed upon another layer.


Subsequently, a third layer is formed above the first and second layers. The third layer is formed upon the first layer as well as the first conductive strip 920 which comprises the second layer. A channel may be grooved into the third layer to provide for the formation of a first via 915. A fourth layer comprising a second conductive strip 940 is formed above the third layer to be connected to a corresponding electrode to be formed upon a subsequent layer. The fourth layer is formed at an offset position relative to the third layer, the second layer (first conductive strip 920), and the first layer. Subsequently, a fifth, non-conductive layer is formed above the conductive fourth layer. The fifth layer may also comprise a groove formation to accommodate the first via 915 as well as a second via 935 to be formed. Further, a sixth layer, comprising a third conductive strip 960 is formed above the fifth layer for electrical coupling with a corresponding electrode to be formed upon a subsequent layer. The sixth layer is formed at an offset position relative to the fifth layer, the fourth layer (second conductive strip 940), the third layer, the second layer (first conductive strip 920), and the first layer. A seventh, non-conductive layer is formed above this sixth layer. Three grooves are formed in the seventh layer to accommodate the first via 915, the second via 935 and a third via 955 to be formed.


Upon the seventh layer, a first electrode 910, a second electrode 930, and a third electrode 950 are formed. However, before the formation of the first through third electrodes, 910, 930, 950, the corresponding vias 915, 935, 955 are formed. The first via 915, that connects the first electrode 910 to the first conductive strip 920, is formed above the second layer and into the grooves that already exist in layers below the electrode, as discussed. Similarly, the second via 935 is formed above the fourth layer to connect the second electrode 930 with the second conductive strip 940. Further, the third via 955 is formed above the sixth layer and in the groove of the seventh layer below the third electrode. The third via 955 is capable of connecting the third electrode 950 to the third conductive strip 960. Therefore, all three electrodes 910, 930, 950, are respectively electrically coupled to the corresponding conductive strips 920, 940, 960. Due to the offsetting of the second, fourth, and sixth layers, both the conductive strips and the subsequently formed electrodes (in other words, the entire conducting structures) are offset from one another, such that all the electrodes are exposed on the surface of the electrode assembly. Further, similar techniques may be used to generate corresponding connection pads that connect to respective conductive strips, and hence to respective electrodes, thereby rendering the electrodes capable of electrical communications with an IMD.


The surface of the electrode assembly 210 is designed so that a conductive electrode is exposed only where it comes into contact with a portion of the patient's body, such that each individual electrode is electrically isolated from the other electrodes and from the conductive strips associated with the other electrodes. Therefore, independent signals may be sent to and from the electrodes 910, 930, 950 via the electrode assembly 210. In this manner, staggering of the time period relating to the delivery of stimulation signals is made possible. Further, independent acquisition of biometric data and delivery of an electrical signal may be performed substantially simultaneously. Utilizing the structure described in FIG. 8, the electrodes 910, 930, 950 are capable of operating independently. Although only three electrodes are illustrated in FIG. 8, those skilled in the art would appreciate that any number of electrodes may be implemented using the technique disclosed in FIG. 8 while still remaining within the spirit and scope of the present invention.


As seen in FIG. 8, all the electrodes 910, 930 and 950 are initially (i.e., prior to shaping the substrate into a helical form) formed to lie in a single plane or substantially in a single plane. In the arrangement illustrated in FIG. 8, this single plane or approximate single plane is the upper surface of the seventh layer. This plane is parallel or substantially parallel to the upper surface of the substrate, upon which the first layer is formed. The arrangement of FIG. 8, in which all the electrodes 910, 930 and 950 are initially formed to lie in a single plane, contrasts with the arrangements shown in FIGS. 6 and 7, in which the electrodes are initially formed in a staggered fashion, such that each electrode lies in a different plane, each of the different planes being parallel or substantially parallel to the upper surface of the substrate (substrate not shown in FIGS. 6 and 7) upon which the first layer is formed.


To be sure, in an arrangement such as any of the arrangements shown in FIGS. 6, 7 and 8, the electrodes may or may not be formed so as to lie in a single plane perpendicular to the upper surface of the substrate upon which the first layer is formed (that single plane would be the plane of the cross-section shown in FIGS. 7 and 8, i.e., the plane of the paper, or a plane parallel thereto). In FIGS. 6, 7 and 8, the electrodes are shown as in fact lying in such a single perpendicular plane, although this need not be the case.


Whether the electrodes are initially formed to lie in a single plane (parallel or perpendicular to the substrate) or in a staggered fashion, once the substrate is shaped into a helical form, the electrodes may lie in a straight line or in a staggered fashion, depending on the diameters of the coils of the helical form. The choice as to whether to make the electrodes lie in a straight line or in a staggered fashion in the finished electrode assembly will depend on the medical indications (e.g., as to where on the target tissue the electrodes should make contact) of the individual case in question for which the assembly is being prepared.


Utilizing embodiments of the present invention, an electrode assembly that comprises an array of electrodes may be deployed to perform various therapy delivery functions and/or sensing functions. Therefore, current steering and targeted delivery of therapeutic electrical signals to different portions of a particular nerve may be performed using the multi-electrode assembly described by embodiments of the present invention. Additionally, electrode assemblies provided by the embodiments of the present invention may be manufactured in a more uniform, dimensionally-controlled, and efficient manner utilizing process methods described herein and known to those skilled in the art of semiconductor manufacturing having benefit of the present disclosure. Embodiments of the present invention provide for more effective therapy and greater efficacy in delivering targeted therapy to various portions of the patient's body.


All of the methods and apparatuses disclosed and claimed herein may be made and executed without undue experimentation in light of the present disclosure. While the methods and apparatuses of this invention have been described in terms of particular embodiments, it will be apparent to those skilled in the art that variations may be applied to the methods and apparatuses and in the steps or in the sequence of steps of the methods described herein without departing from the concept, spirit, and scope of the invention, as defined by the appended claims. It should be especially apparent that the principles of the invention may be applied to selected cranial nerves other than the vagus nerve to achieve particular results.


The particular embodiments disclosed above are illustrative only, as the invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design herein shown other than as described in the claims below. It is, therefore, evident that the particular embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the invention. Accordingly, the protection sought herein is as set forth in the claims below.

Claims
  • 1. A method for forming a helical electrode assembly for carrying a signal associated with an implantable medical device, comprising: forming a first layer on a generally flat substrate;forming a first conducting structure as a second layer upon said first layer, said second layer comprising a first electrode and a first conductive strip operatively coupled to said first electrode;forming a third, non-conductive layer above said first and second layers;forming a second conducting structure as a fourth layer upon said third layer, said fourth layer comprising a second electrode and a second conductive strip operatively coupled to said second electrode; andforming at least a portion of said generally flat substrate and the first, second, third and fourth layers into a helical structure,wherein forming said third layer comprises forming the third layer at an offset position on the second layer such that the third layer does not overlap the region in which the first electrode resides, such that a stair step of layers that contain electrodes and conductive strips is generated.
  • 2. The method of claim 1, wherein forming said first and second conducting structures comprises: performing a photolithography process to imprint said first conducting structure upon said first layer and said second conducting structure upon said third layer; andperforming an etch process to control at least one dimension relating to each of said first and second conducting structures within respective predetermined tolerances.
  • 3. The method of claim 1, wherein forming said first and second conducting structures comprises: performing a metal deposition process to deposit a conductive material for forming said first and second conducting structures; andperforming an etch process to control at least one dimension relating to each of said first and second conducting structures within predetermined tolerances.
  • 4. The method of claim 1, further comprising: forming a fifth, non-conducting layer above said third and fourth layers, and forming a third conducting structure as a sixth layer upon said fifth layer, said third conducting structure comprising a third electrode and a third conducting strip operatively coupled to said third electrode; andforming a seventh non-conducting layer above said fifth and sixth layers, and forming a fourth conducting structure as an eighth layer upon said seventh layer, said fourth conducting structure comprising a fourth electrode and a fourth conducting strip operatively coupled to said fourth electrode.
  • 5. The method of claim 1, further comprising: forming a first connection pad on the surface of said electrode assembly, said first connection pad being electrically coupled to said first conductive strip; andforming a second connection pad on the surface of said electrode assembly, said second connection pad being electrically coupled to said second conductive strip.
  • 6. A method for forming a helical electrode assembly for carrying an electrical signal associated with an implantable medical device, comprising: forming a plurality of layers on a generally flat substrate, including a first conducting structure and a second conducting structure as two of the plurality of layers; andforming at least a portion of said generally flat substrate into a helical structure,wherein said first conducting structure comprises a first electrode and a first conductive strip operatively coupled to said first electrode, and said second conducting structure comprises a second electrode and a second conductive strip operatively coupled to said second electrode,wherein said first and second conducting structures are formed to be electrically isolated from one another, such that said first and second electrodes may be operated independently of one another, andwherein forming said first and second conducting structures comprises offsetting said first conducting structure from said second conducting structure such that the second conducting structure does not overlap the region in which the first electrode resides, such that a stair step of layers that contain electrodes and conductive strips is generated.
  • 7. The method of claim 6, wherein said first and second conducting structures are formed by (i) a photolithography process or a metal deposition process, and (ii) an etch process to control at least one dimension relating to each of said first and second conducting structures within respective predetermined tolerances.
  • 8. The method of claim 7, further comprising performing a chemical-mechanical polishing process.
  • 9. The method of claim 6, wherein said first and second conducting structures are formed to be electrically isolated from one another by forming a non-conductive layer therebetween.
  • 10. The method of claim 6, wherein said plurality of layers comprises alternating non-conductive and conductive layers.
  • 11. The method of claim 10, wherein said plurality of layers comprises four or more layers.
  • 12. The method of claim 6, wherein said first and second electrodes are formed to lie on an interior surface of said helical structure, in a linear or staggered arrangement.
  • 13. The method of claim 6, wherein said helical structure includes an elastomeric body portion comprising a material selected from the group consisting of silicone rubbers, siloxane polymers, polydimethylsiloxanes, polyurethane, polyether urethane, polyetherurethane urea, polyesterurethane, polyamide, polycarbonate, polyester, polypropylene, polyethylene, polystyrene, polyvinyl chloride, polytetrafluoroethylene, polysulfone, cellulose acetate, polymethylmethacrylate, polyethylene, and polyvinylacetate, and each of said first and second electrodes comprises a material selected from the group consisting of platinum, iridium, platinum/iridium alloys, and oxides thereof.
  • 14. The method of claim 6, wherein said helical structure is coupled to a lead assembly via an interface, said lead assembly being coupled to the implantable medical device.
  • 15. The method of claim 6, further comprising: forming a first connection pad on the surface of said electrode assembly, said first connection pad being electrically coupled to said first conductive strip; andforming a second connection pad on the surface of said electrode assembly, said second connection pad being electrically coupled to said second conductive strip.
  • 16. The method of claim 6, further comprising: forming a first via to electrically couple said first conductive strip to said first electrode; andforming a second via to electrically couple said second conductive strip to said second electrode.
  • 17. An electrode assembly for conducting electrical signals between an implantable medical device and a target tissue, comprising: a helical member;a first layer formed on the helical member;a first conducting structure as a second layer formed upon said first layer, said second layer comprising a first electrode and a first conductive strip operatively coupled to said first electrode;a third, non-conductive layer formed above said first and second layers;a second conducting structure as a fourth layer formed upon said third layer, said fourth layer comprising a second electrode and a second conductive strip operatively coupled to said second electrode; andwherein said third layer is formed at an offset position on the second layer such that the third layer does not overlap the region in which the first electrode resides, such that a stair step of layers that contain electrodes and conductive strips is generated.
  • 18. The electrode assembly of claim 17, wherein said first and second conductive strips are positioned in at least a partially parallel configuration along the length of at least a portion of said helical member.
  • 19. The electrode assembly of claim 17, further comprising a fifth, non-conductive layer formed above said first to fourth layers and a third conducting structure as a sixth layer formed upon said fifth layer, said sixth layer comprising a third electrode and a third conductive strip operatively coupled to said third electrode, wherein said first, second, and third electrodes form an electrode array.
  • 20. The electrode assembly of claim 19, wherein said first electrode is adapted to carry a first electrical signal, said second electrode is adapted to carry a second electrical signal different from said first electrical signal, and said third electrode is adapted to carry a third electrical signal different from said first and second electrical signals.
  • 21. The electrode assembly of claim 17, further comprising a first lead wire operatively coupled to said first conductive strip and a second lead wire operatively coupled to said second conductive strip.
  • 22. The electrode assembly of claim 21, further comprising a lead interface operatively coupled to said helical member, said first and second lead wires being operatively coupled to said first and second conductive strips via said lead interface.
  • 23. The electrode assembly of claim 17, wherein said helical material comprises a material selected from the group consisting of siloxane polymers, polydimethylsiloxanes, silicone rubbers, polyurethane, polyether urethane, polyetherurethane urea, polyesterurethane, polyamide, polycarbonate, polyester, polypropylene, polyethylene, polystyrene, polyvinyl chloride, polytetrafluoroethylene, polysulfone, cellulose acetate, polymethylmethacrylate, polyethylene, and polyvinylacetate, and said first and second electrodes comprises a material selected from the group consisting of platinum, iridium, and platinum/iridium alloys.
  • 24. The electrode assembly of claim 17, wherein said helical member is capable of being wrapped around a nerve, wherein said first and second electrodes come into electrical contact with said nerve to deliver a stimulation signal in a cascading manner.
CROSS-REFERENCE TO RELATED APPLICATIONS

This patent application is a divisional application Ser. No. 11/494,057, filed Jul. 26, 2006, published as U.S. Patent Application No. 2008/0027524, now abandoned, the contents of which is incorporated herein by reference.

US Referenced Citations (240)
Number Name Date Kind
3421511 Schwartz et al. Jan 1969 A
3760812 Timm et al. Sep 1973 A
3796221 Hagfors Mar 1974 A
4291699 Geddes et al. Sep 1981 A
4305402 Katims Dec 1981 A
4384926 Wagner May 1983 A
4407303 Akerstrom Oct 1983 A
4458696 Larimore Jul 1984 A
4459989 Borkan Jul 1984 A
4573481 Bullara Mar 1986 A
4590946 Loeb May 1986 A
4592359 Galbraith Jun 1986 A
4606349 Livingston et al. Aug 1986 A
4608985 Crish et al. Sep 1986 A
4612934 Borkan Sep 1986 A
4628942 Sweeney et al. Dec 1986 A
4630615 Yomtov Dec 1986 A
4649936 Ungar et al. Mar 1987 A
4702254 Zabara Oct 1987 A
4793353 Borkan Dec 1988 A
4821724 Whigham et al. Apr 1989 A
4827932 Ideker et al. May 1989 A
4850356 Heath Jul 1989 A
4860616 Smith Aug 1989 A
4867164 Zabara Sep 1989 A
4870341 Pihl et al. Sep 1989 A
4899750 Ekwall Feb 1990 A
4903700 Whigham et al. Feb 1990 A
4920979 Bullara May 1990 A
4964407 Baker, Jr. et al. Oct 1990 A
4969468 Byers et al. Nov 1990 A
4979511 Terry, Jr. Dec 1990 A
5003975 Hafelfinger et al. Apr 1991 A
5025807 Zabara Jun 1991 A
5095905 Klepinski Mar 1992 A
5111815 Mower May 1992 A
5137020 Wayne et al. Aug 1992 A
5137021 Wayne et al. Aug 1992 A
5139028 Steinhaus et al. Aug 1992 A
5146920 Yuuchi et al. Sep 1992 A
5154172 Terry, Jr. et al. Oct 1992 A
5179950 Stanislaw Jan 1993 A
5186170 Varrichio et al. Feb 1993 A
5188104 Wernicke et al. Feb 1993 A
5201808 Steinhaus et al. Apr 1993 A
5201865 Kuehn Apr 1993 A
5205285 Baker, Jr. Apr 1993 A
5215086 Terry, Jr. et al. Jun 1993 A
5215089 Baker, Jr. Jun 1993 A
5222494 Baker, Jr. Jun 1993 A
5237991 Baker, Jr. et al. Aug 1993 A
5251634 Weinberg Oct 1993 A
5263480 Wernicke et al. Nov 1993 A
5269303 Wernicke et al. Dec 1993 A
5282468 Klepinski Feb 1994 A
5299569 Wernicke et al. Apr 1994 A
5304206 Baker, Jr. et al. Apr 1994 A
5324322 Grill, Jr. et al. Jun 1994 A
5330515 Rutecki et al. Jul 1994 A
5335657 Terry, Jr. et al. Aug 1994 A
5351394 Weinberg Oct 1994 A
5411528 Miller et al. May 1995 A
5431692 Hansen et al. Jul 1995 A
5466255 Franchi Nov 1995 A
5501702 Plicchi et al. Mar 1996 A
5507786 Morgan et al. Apr 1996 A
5522865 Schulman et al. Jun 1996 A
5531778 Maschino et al. Jul 1996 A
5534018 Wahlstrand et al. Jul 1996 A
5540730 Terry, Jr. et al. Jul 1996 A
5540734 Zabara Jul 1996 A
5549646 Katz et al. Aug 1996 A
5571150 Wernicke et al. Nov 1996 A
5575813 Edell et al. Nov 1996 A
5620474 Koopman Apr 1997 A
5658318 Stroetmann et al. Aug 1997 A
5689877 Grill, Jr. et al. Nov 1997 A
5690681 Geddes et al. Nov 1997 A
5700282 Zabara Dec 1997 A
5707400 Terry, Jr. et al. Jan 1998 A
5713936 Staub et al. Feb 1998 A
5720099 Parker et al. Feb 1998 A
5741311 Mc Venes et al. Apr 1998 A
5743860 Hively et al. Apr 1998 A
5755742 Schuelke et al. May 1998 A
5755747 Daly et al. May 1998 A
5759199 Snell et al. Jun 1998 A
5769873 Zadeh Jun 1998 A
5796044 Cobian et al. Aug 1998 A
5814088 Paul et al. Sep 1998 A
5876425 Gord et al. Mar 1999 A
5891179 Er et al. Apr 1999 A
5897577 Cinbis et al. Apr 1999 A
5916239 Geddes et al. Jun 1999 A
5919220 Stieglitz et al. Jul 1999 A
5928272 Adkins et al. Jul 1999 A
5995868 Osorio et al. Nov 1999 A
6035237 Schulman et al. Mar 2000 A
6052624 Mann Apr 2000 A
6073050 Griffith Jun 2000 A
6104956 Naritoku et al. Aug 2000 A
6154678 Lauro Nov 2000 A
6171239 Humphrey Jan 2001 B1
6181969 Gord Jan 2001 B1
6208902 Boveja Mar 2001 B1
6212431 Hahn et al. Apr 2001 B1
6216045 Black et al. Apr 2001 B1
6259951 Kuzma et al. Jul 2001 B1
6269270 Boveja Jul 2001 B1
6304787 Kuzma et al. Oct 2001 B1
6317633 Jorgenson et al. Nov 2001 B1
6339725 Naritoku et al. Jan 2002 B1
6341236 Osorio et al. Jan 2002 B1
6393325 Mann et al. May 2002 B1
6400988 Gurewitsch Jun 2002 B1
6418348 Witte Jul 2002 B1
6445951 Mouchawar Sep 2002 B1
6453198 Torgerson et al. Sep 2002 B1
6456481 Stevenson Sep 2002 B1
6473653 Schallhorn et al. Oct 2002 B1
6477417 Levine Nov 2002 B1
6490486 Bradley Dec 2002 B1
6505074 Boveja et al. Jan 2003 B2
6510332 Greenstein Jan 2003 B1
6529774 Greene Mar 2003 B1
6553263 Meadows et al. Apr 2003 B1
6556868 Naritoku et al. Apr 2003 B2
6587719 Barrett et al. Jul 2003 B1
6587727 Osorio et al. Jul 2003 B2
6600956 Maschino et al. Jul 2003 B2
6600957 Gadsby Jul 2003 B2
6606523 Jenkins Aug 2003 B1
6609025 Barrett et al. Aug 2003 B2
6620186 Saphon et al. Sep 2003 B2
6622038 Barrett et al. Sep 2003 B2
6622041 Terry, Jr. et al. Sep 2003 B2
6622047 Barrett et al. Sep 2003 B2
6648823 Thompson Nov 2003 B2
6658294 Zadeh et al. Dec 2003 B1
6662053 Borkan Dec 2003 B2
6671556 Osorio et al. Dec 2003 B2
6684105 Cohen et al. Jan 2004 B2
6687538 Hrdlicka et al. Feb 2004 B1
6690974 Archer et al. Feb 2004 B2
6711440 Deal et al. Mar 2004 B2
6718203 Weiner et al. Apr 2004 B2
6718207 Connelly Apr 2004 B2
6721600 Jorgenson et al. Apr 2004 B2
6721603 Zabara et al. Apr 2004 B2
6725092 MacDonald et al. Apr 2004 B2
6731979 MacDonald May 2004 B2
6745077 Griffith et al. Jun 2004 B1
6754539 Erickson et al. Jun 2004 B1
6757566 Weiner et al. Jun 2004 B2
6760624 Anderson et al. Jul 2004 B2
6760625 Kroll Jul 2004 B1
6760628 Weiner et al. Jul 2004 B2
6763268 MacDonald et al. Jul 2004 B2
6778856 Connelly et al. Aug 2004 B2
6792316 Sass Sep 2004 B2
6795730 Connelly et al. Sep 2004 B2
6795736 Connelly et al. Sep 2004 B2
6799069 Weiner et al. Sep 2004 B2
6804557 Kroll Oct 2004 B1
6819954 Connelly Nov 2004 B2
6819958 Weiner et al. Nov 2004 B2
6829509 MacDonald et al. Dec 2004 B1
6843870 Bluger Jan 2005 B1
6845266 Weiner et al. Jan 2005 B2
6850805 Connelly et al. Feb 2005 B2
6875180 Weiner et al. Apr 2005 B2
6901290 Foster et al. May 2005 B2
6906256 Wang Jun 2005 B1
6907295 Gross et al. Jun 2005 B2
6920357 Osorio et al. Jul 2005 B2
6925328 Foster et al. Aug 2005 B2
6944489 Zeijlemaker et al. Sep 2005 B2
6949929 Gray et al. Sep 2005 B2
6954674 Connelly Oct 2005 B2
6961618 Osorio et al. Nov 2005 B2
6985775 Reinke et al. Jan 2006 B2
6993387 Connelly et al. Jan 2006 B2
7006859 Osorio et al. Feb 2006 B1
7010357 Helfer et al. Mar 2006 B2
7013174 Connelly et al. Mar 2006 B2
7015393 Weiner et al. Mar 2006 B2
7047074 Connelly et al. May 2006 B2
7054686 MacDonald May 2006 B2
7107097 Stern et al. Sep 2006 B2
7123013 Gray Oct 2006 B2
7171166 Ng et al. Jan 2007 B2
7174219 Wahlstrand et al. Feb 2007 B2
7203548 Whitehurst et al. Apr 2007 B2
7212869 Wahlstrom et al. May 2007 B2
7221981 Gliner May 2007 B2
7239924 Kolberg Jul 2007 B2
7289856 Karicherla Oct 2007 B1
7584004 Caparso et al. Sep 2009 B2
20020072782 Osorio et al. Jun 2002 A1
20030083726 Zeijlemaker et al. May 2003 A1
20030195601 Hung et al. Oct 2003 A1
20040015205 Whitehurst et al. Jan 2004 A1
20040147992 Bluger et al. Jul 2004 A1
20040167583 Knudson et al. Aug 2004 A1
20040172088 Knudson et al. Sep 2004 A1
20040210291 Erickson Oct 2004 A1
20050015128 Rezai et al. Jan 2005 A1
20050016657 Bluger Jan 2005 A1
20050107858 Bluger May 2005 A1
20050154426 Boveja et al. Jul 2005 A1
20050154435 Stern et al. Jul 2005 A1
20050222642 Przybyszewski et al. Oct 2005 A1
20050272280 Osypka Dec 2005 A1
20060058597 Machado et al. Mar 2006 A1
20060106430 Fowler et al. May 2006 A1
20060167497 Armstrong et al. Jul 2006 A1
20060173493 Armstrong et al. Aug 2006 A1
20060184211 Gaunt et al. Aug 2006 A1
20060224199 Zeijlemaker Oct 2006 A1
20060253164 Zhang et al. Nov 2006 A1
20060265025 Goetz et al. Nov 2006 A1
20070027497 Parnis et al. Feb 2007 A1
20070027498 Maschino et al. Feb 2007 A1
20070027500 Maschino et al. Feb 2007 A1
20070032834 Gliner et al. Feb 2007 A1
20070060991 North et al. Mar 2007 A1
20070073150 Gopalsami et al. Mar 2007 A1
20070100392 Maschino et al. May 2007 A1
20070142889 Whitehurst et al. Jun 2007 A1
20070173902 Maschino et al. Jul 2007 A1
20070179557 Maschino et al. Aug 2007 A1
20070179579 Feler et al. Aug 2007 A1
20070179584 Gliner Aug 2007 A1
20080033503 Fowler et al. Feb 2008 A1
20080046035 Fowler et al. Feb 2008 A1
20080071323 Lowry et al. Mar 2008 A1
20080200925 Johnson Aug 2008 A1
20080215110 Gunderson et al. Sep 2008 A1
20080255582 Harris Oct 2008 A1
20090076567 Fowler et al. Mar 2009 A1
Foreign Referenced Citations (7)
Number Date Country
197 50 043 May 1999 DE
1 790 380 May 2007 EP
9728668 Aug 1997 WO
9949934 Oct 1999 WO
2004069330 Aug 2004 WO
2005114720 Dec 2005 WO
2006018447 Feb 2006 WO
Non-Patent Literature Citations (4)
Entry
J. Walter Woodbury and Dixon M. Woodbury, Vagal Stimulation Reduces the Severity of Maximal Electroshock Seizures in Intact Rates: Use of a Cuff Electrode for Stimulating and Recording, Department of Physiology, School of Medicine, University of Utah, Jan. 1991, pp. 94-107, vol. 14, Salt Lake City, Utah.
Mesut Sahin, Improved Nerve Cuff Electrode Recordings with Subthreshold Anodic Currents, IEEE Transactions on Biomedical Engineering, Aug. 1998, pp. 1044-1050, vol. 45, No. 8.
Peter J. Basser and Bradley J. Roth, New Currents in Electrical Stimulation of Excitable Tissues, Annu. Rev. Biomed. Eng. 2000, vol. 2, pp. 377-397.
PCT/US2007/016345 Search Report (Dec. 5, 2007).
Related Publications (1)
Number Date Country
20100192374 A1 Aug 2010 US
Divisions (1)
Number Date Country
Parent 11494057 Jul 2006 US
Child 12757002 US